Skip to main content
OpenTrials
Completed

NCT Number: NCT02469727

mHealth Intervention to Promote Cancer Survivors' Physical Activity

The Primary Goal is to conduct a 5-10 week randomized controlled trial (RCT) of the Fitbit Flex, a popular, affordable, wearable physical activity tracking device, and the Fitbit mHealth app. The target population will be childhood cancer survivors 14-18 years old recruited from Seattle Children's Hospital. For the intervention group, peer influences will be engaged via a private, social network (e.g. a Facebook group) customized for survivors. Measurements will be completed (1) at baseline, prior to randomization, and (2) during the final week of the intervention period (follow-up measure). This study will provide initial proof of concept and allow for further customization of the intervention for childhood cancer survivors in anticipation of a future, larger proposal to study physical activity and related outcomes over a multi-year period.

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seattle Children's Research Institute

Seattle, Washington, 98145-5005, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • in remission for childhood cancer and previously treated for childhood cancer at Seattle Children's Hospital
  • ≥1-year post-cancer therapy
  • ambulatory without any known medical contraindications to participation
  • able to complete surveys in English
  • agree to install and share data from the FitBit smart phone app with the investigators

Exclusion criteria

  • currently or previously used a wearable physical activity sensing device to improve physical activity

Treatment and study plan

Fitbit

Behavioral

Participants will use the FitBit device to track their physical activity

Facebook Group

Behavioral

Participants will receive and post messages and receive badges on the Facebook group

Primary outcomes

  1. Post-intervention physical activity (measured by accelerometers)

    Time frame: up to week 10

Secondary outcomes

  1. Post-intervention health related quality of life (measured by questionnaire)

    Time frame: up to week 10

Sponsors and collaborators

Lead sponsor

Seattle Children's Hospital

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jun 11, 2015
Registry last updated
Oct 13, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.